Tempe medical device firm raises $45M to expand technology to treat brain tumors
Tempe-based GT Medical Technologies Inc. raised $45 million to expand its technology to treat patients with operable brain tumors. The funding will be used to expand the company’s commercialization of its GammaTile Therapy, a targeted radiation therapy the U.S. Food and Drug Administration cleared in July 2018 for patients with operable brain tumors.